Makes robotic laser systems that help surgeons perform cataract surgery with more precision, like a GPS-guided scalpel for the eye.
Sells laser systems and related procedure equipment; recent quarterly net margin hit 21.43% on 0.02B revenue, though annual net income has been negative since 2023.
Proprietary imaging and robotics tech used in surgery at J&J and Alcon's expense, but no visible durable brand lock-in or network effect; sales depend on winning individual hospital contracts.
Key events, in time order
Q2 revenue up 18%, recurring revenue $13.7M, 10 ALLY placements, 13 backlog, US procedural market share 24.5%
None yet
None yet
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
